Used in the synthesis of antiviral agents, particularly as an intermediate in the development of nucleoside analogs. These analogs are designed to inhibit viral replication by mimicking natural nucleosides, thereby interfering with viral RNA or DNA synthesis. Shows potential in pharmaceutical research for treating RNA virus infections due to its structural similarity to ribose-containing nucleosides. Also investigated for use in prodrug formulations to enhance bioavailability and cellular uptake.